ICHR · Ichor Holdings

The thesis

Ichor Holdings' recovery case has weakened sharply: the shares closed at $37.86 on 22 October 2026, down 51.6% over three months, and the 2 November 2026 third-quarter report against the $315–345 million revenue guide now settles whether the selloff overshot. Ichor makes fluid-delivery subsystems for chip-making equipment, and the business facts have not changed since the 3 August 2026 report.

The price level in the prior note has been breached. The shares closed at $59.91 on 9 October 2026, then fell to $43.34 on 21 October 2026 and $37.86 on 22 October 2026, 66.3% below the 52-week high of $112.28. MarketBeat reported the 22 October 2026 gap down without a stated cause, and no Ichor filing or news release explains it.

The narrative is fading: the recovery story built on the 15 September 2026 low of $50.02 has reversed, and the next dated test is the 2 November 2026 report. Third-quarter revenue at or above $315 million, with free cash flow turning positive, would restore the operating case. Revenue below that floor would break it.

Bullish and bearish views on Ichor Holdings

The bull case on Ichor Holdings (ICHR), in brief: Guidance still sits above the last quarter. The bear case: The price has broken every recent level.

Bull case

• Guidance still sits above the last quarter. Ichor's 3 August 2026 release guided third-quarter revenue to $315–345 million, after second-quarter revenue of $294.8 million, up 24% year over year. MarketBeat lists third-quarter earnings per share guidance of $0.40 to $0.50.
• Equipment demand is rising at the customers' level. Lam Research guided its September quarter to about $8.1 billion of revenue on 29 July 2026 and raised its 2026 wafer fab equipment outlook to the low $150 billion range from $140 billion, according to MarketBeat and CryptoBriefing coverage of the call. Lam is one of two customers behind roughly 90% of Ichor's revenue.
• Memory customers are spending. Micron's 30 September 2026 release reported fiscal fourth-quarter revenue of $54.23 billion and fiscal 2026 net capital expenditures of $27.37 billion. It guided fiscal first-quarter 2027 revenue to $61.5 billion, plus or minus $1.5 billion.
• Analysts still carry targets far above the price. MarketBeat reports a consensus target of $85.89 as of 22 October 2026, from one Strong Buy, six Buy, two Hold and one Sell rating. Freedom Broker began coverage on 9 October 2026 with a buy rating and an $82 target.

Bear case

• The price has broken every recent level. The 22 October 2026 close of $37.86 is under the 15 September 2026 low of $50.02 and the 5 June 2026 low of $62.91. MarketBeat put the 50-day moving average at $56.63 and the 200-day at $69.55 on 22 October 2026.
• Growth consumed cash. Ichor's 3 August 2026 release reported second-quarter free cash flow of negative $23.6 million and inventories of $290.7 million. Another quarter of rising sales with negative free cash flow would keep that concern open.
• Second-quarter revenue missed. Revenue of $294.78 million fell short of the $300.17 million forecast, per MarketBeat, even as earnings per share of $0.34 beat the $0.31 estimate.
• Equity was issued into strength. Ichor's 3 August 2026 release stated that its $200 million at-the-market equity program was completed during the second quarter.
• Insiders sold into higher prices. SEC Form 4 filings reported by MarketBeat show director Iain MacKenzie sold 20,000 shares on 15 September 2026 at an average of $50.66, and chief financial officer Greg Swyt sold 689 shares on 2 October 2026 at $65.01. Both sales were under pre-arranged 10b5-1 plans.
• Two customers dominate. Lam Research and Applied Materials together account for roughly 90% of revenue, so a spending cut at either flows directly to Ichor.

Price setup

Adjusted daily closes show $37.86 on 22 October 2026, with the 14-day relative strength index at 13.0, a reading that marks the selloff as extreme. The shares are 66.3% below the 52-week high of $112.28 and below both the 50-day and 200-day moving averages reported by MarketBeat. The all-time high was $113.58 on 1 July 2026, per AD HOC News.

The decline came in steps: a $42.11 trade on 16 October 2026 after a 9.73% one-day fall, a $43.34 close on 21 October 2026, then a 22 October 2026 open of $40.11 and a close of $37.86.

Crowding evidence is limited. The shares have a beta of 1.79 per MarketBeat, and the earnings date is 11 days away. Zacks Research downgraded the shares from strong-buy to hold on 5 October 2026.

Catalysts, next 30 days

• Revenue is tested against the $315–345 million guide, and free cash flow against negative $23.6 million in the second quarter.

Elapsed catalysts

• ~28 October 2026, est.: Lam Research fiscal first-quarter 2027 results. Lam has not confirmed the date in anything found for this note. Its prior September-quarter report came on 22 October 2025, and its spending commentary is the closest outside read on Ichor's orders. (passed 9d ago)

What would change the view

The case breaks if Ichor reports third-quarter revenue below the $315 million guidance floor, or if free cash flow stays negative while sales rise. A cut to equipment-demand commentary from Lam Research or Applied Materials would break it as well. A daily close below $33 would show the selloff continuing past the 22 October 2026 close.

The case strengthens if revenue lands inside the guided range and management describes fourth-quarter orders at or above the third-quarter level. A weekly close back above the 15 September 2026 low of $50.02 would show the October decline has reversed.

What it trades with

Ichor's orders follow Lam Research and Applied Materials, so their quarterly guidance and the Micron capital-spending outlook move the shares. The 1.79 beta reported by MarketBeat means the shares have swung more than the broad market. Both customers' reports precede or follow Ichor's own, so the sequence of reports matters more than any single one.